Edwards Lifesciences (EW) Shares Outstanding (2010 - 2026)

Edwards Lifesciences has reported Shares Outstanding for 17 years, with the latest figure at $660.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 0.63% year-over-year to $660.0 million; the trailing twelve-month figure through Mar 2026 stood at $660.0 million (up 0.63% YoY), and the FY2025 full-year result was $580.7 million, down 11.32% from the prior year.
• Shares Outstanding for Q1 2026 stood at $660.0 million, up from $580.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $658.2 million in Q3 2025, with the low at $577.0 million in Q1 2026.
• Average Shares Outstanding over 5 years is $642.4 million, with a median of $649.9 million recorded in 2023.
• Year-over-year, Shares Outstanding rose 0.85% in 2022 and retreated 11.32% in 2025.
• Tracing EW's Shares Outstanding over 5 years: stood at $646.3 million in 2022, then climbed by 0.65% to $650.5 million in 2023, then gained by 0.66% to $654.8 million in 2024, then retreated by 11.32% to $580.7 million in 2025, then gained by 13.66% to $660.0 million in 2026.
• The last three Shares Outstanding figures came in at $660.0 million (Q1 2026), $580.7 million (Q4 2025), and $580.7 million (Q3 2025), per Business Quant data.

Peer Comparison